CMS Initiative To Lower Antipsychotic Drug Use In Nursing Homes Showing Success
This article was originally published in The Pink Sheet Daily
Executive Summary
A program launched in 2012, the National Partnership to Improve Dementia Care, is on its way to meeting goals of lowering the use of antipsychotic drugs in nursing homes by 15%, with 11 states already hitting that target.
You may also be interested in...
CMS Plan To Reduce Antipsychotic Use In Nursing Homes By 15% Plays Up Non-Regulatory Approaches
Efforts will include provider training, posting of nursing home prescribing rates on Medicare’s Nursing Home Compare website.
Nursing Home Overprescribing: CMS Urges Voluntary Remedies, Withholds Regulation
CMS will not implement an earlier regulatory proposal requiring that consultant pharmacists maintain independence from long-term care facilities or drug firms at this point.
CMS Targeting LTC Facility Overprescribing, Citing Antipsychotics
The Centers for Medicare and Medicaid Services is proposing a new Medicare requirement that consulting pharmacists serving long-term care facilities maintain independence from the facility to help avoid drug “overprescribing and overutilization.”